EUVIMED · CrossrefZeitschrift
NCODA Oncology and Hematology Meeting Abstracts
ISSN 3071-6462 · Network for Collaborative Oncology Development & Advancement (NCODA)
Neueste Artikel
Closing the oncology education gap: Design and implementation of NCODA’s Oncology Fundamentals and Business of Oncology courses
Addressing bispecific antibody education gaps on an inpatient oncology unit through in-person education and surveys
Caregiver callbacks: Optimizing the caregiver experience in the month following bispecific T-cell engager step-up therapy through a collaborative clinic nursing and navigation process
Exploring oncology pharmacy awareness: A nationwide study among pharmacy students in Türkiye
Circulating tumor DNA as a biomarker to guide treatment escalation and de-escalation in nonsmall cell lung cancer: A review of the current evidence
Expanded institutional experience with prophylactic tocilizumab for outpatient bispecific antibody administration in community oncology
Exploring key considerations for subcutaneous anticancer therapies
Cutaneous recurrence of extramedullary multiple myeloma within surgical scar tissue
Building competency in oral anticancer medication adherence: A survey-driven education and training initiative across a multi-site oncology system
Advancing global learning in oncology through international collaboration: NCODA’s Global Congress
Assessing value-based care metrics and clinical outcomes by hormone receptor status among patients with human epidermal growth factor receptor 2-positive breast cancer
Bringing clinical leadership together: An interprofessional approach to quality and operational excellence
Re-engineering systemic anticancer therapy delivery: A multi-faceted model for enhancing oncology day ward capacity and key performance indicators
Financial toxicity’s new face: How Medicaid unwinding, insurance changes, and rising cost of living are reshaping cancer care
Beyond staffing gaps: A scalable nursing float pool model for integrated oncology care
Developing a comprehensive community-based bispecific antibody operations program for safe step-up dosing and ongoing management
Durable efficacy and safety with lovotibeglogene autotemcel for sickle cell disease
Evaluation of patient- and treatment-related factors in patients with venous thromboembolism managed within a pediatric cancer center
Gedatolisib plus fulvestrant, with and without palbociclib, versus fulvestrant in patients with HR+/ HER2-/PIK3CA wild-type advanced breast cancer: first results from VIKTORIA-1
Effect of bezuclastinib on the pathobiology of mastocytosis: changes in bone marrow mast cells, tryptase, and KIT p.D816V variant allele frequency from the pivotal SUMMIT trial
Four-year survival outcomes with dostarlimab plus chemotherapy in mismatch repair–deficient or microsatellite instability–high primary advanced or recurrent endometrial cancer in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial
Real-world treatment patterns and clinical outcomes in patients with myelofibrosis treated with pacritinib with platelets ≥50 × 10⁹/L at treatment initiation: interim results from the MY-PAC study
EUVIMED